Similar articles

• Cell-mediated cytotoxic mechanisms.

  Squier MK, Cohen JJ. Squier MK, et al. Curr Opin Immunol. 1994 Jun;6(3):447-52. doi: 10.1016/0952-7915(94)90126-0. Curr Opin Immunol. 1994. PMID: 7522467 Review.
• How do cytotoxic lymphocytes kill their targets?

  Shresta S, Pham CT, Thomas DA, Graubert TA, Ley TJ. Shresta S, et al. Curr Opin Immunol. 1998 Oct;10(5):581-7. doi: 10.1016/s0952-7915(98)80227-6. Curr Opin Immunol. 1998. PMID: 9794837 Review.
• Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.

  Kafrouni MI, Brown GR, Thiele DL. Kafrouni MI, et al. J Immunol. 2001 Aug 1;167(3):1566-74. doi: 10.4049/jimmunol.167.3.1566. J Immunol. 2001. PMID: 11466378
• Role of perforin, granzymes and the proliferative state of the target cells in apoptosis and necrosis mediated by bispecific-antibody-activated cytotoxic T cells.

  Renner C, Held G, Ohnesorge S, Bauer S, Gerlach K, Pfitzenmeier JP, Pfreundschuh M. Renner C, et al. Cancer Immunol Immunother. 1997 Apr;44(2):70-6. doi: 10.1007/s002620050357. Cancer Immunol Immunother. 1997. PMID: 9177467 Free PMC article.
• Fas-independent and nonapoptotic cytotoxicity mediated by a human CD4(+) T-cell clone directed against an acute myelogenous leukemia-associated DEK-CAN fusion peptide.

  Ohminami H, Yasukawa M, Kaneko S, Yakushijin Y, Abe Y, Kasahara Y, Ishida Y, Fujita S. Ohminami H, et al. Blood. 1999 Feb 1;93(3):925-35. Blood. 1999. PMID: 9920842